Arvinas (ARVN) Receivables (2017 - 2026)
Arvinas (ARVN) posted Receivables of $5.3 million for Q3 2026, down 80.2% from $26.8 million a year earlier and down 90.2% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas' Receivables came in at $6.4 million, down 53.3% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- In prior years, Arvinas' Receivables was $13.7 million in FY2024 (+90.3%), $7.2 million in FY2023 (-10.0%), $8 million in FY2022 (-68.9%) and $25.7 million in FY2021 (+206.0%).
- The Q3 2026 figure stands as the lowest quarterly Receivables since Q2 2023.
- On a year-over-year basis, Receivables increased in four of the last eight quarters, with growth averaging 52.0%.
- The strongest year-over-year quarter for Receivables in the past five years was Q2 2026, with growth of 389.2%; the weakest was Q3 2026, with a decline of 80.2%.
- According to Business Quant data, Receivables for the three prior quarters was $54.3 million (Q2 2026), $6.4 million (Q1 2026) and $6.4 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 | 5.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.30 Mn |
| Jun 30, 2026 | 54.30 Mn |
| Mar 31, 2026 | 6.40 Mn |
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 11.10 Mn |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 14.80 Mn |
| Jun 30, 2024 | 11.80 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Dec 31, 2023 | 7.20 Mn |
| Sep 30, 2023 | 20.60 Mn |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | 4.70 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 6.80 Mn |
| Jun 30, 2022 | 8.10 Mn |
| Mar 31, 2022 | 6.70 Mn |
| Dec 31, 2021 | 25.70 Mn |
API Access
Arvinas Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();